Utah Medical Products (UTMD) Cost of Revenue (2010 - 2026)

Utah Medical Products' Cost of Revenue history runs 17 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• In Q1 2026, Cost of Revenue fell 17.55% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $1.3 million (down 11.95% YoY), while the FY2025 annual figure was $2.1 million, up 7.89% from the prior year.
• Cost of Revenue was $3.4 million for Q1 2026 at Utah Medical Products, up from -$10.7 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $5.3 million in Q2 2022 to a low of -$13.3 million in Q4 2022.
• Historically, Cost of Revenue has averaged $1.7 million across 5 years, with a median of $4.4 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Cost of Revenue tumbled 377.67% in 2022, then soared 139.27% in 2023.
• A 5-year view of Cost of Revenue shows it stood at -$13.3 million in 2022, then surged by 139.27% to $5.2 million in 2023, then slumped by 310.58% to -$11.0 million in 2024, then increased by 3.06% to -$10.7 million in 2025, then surged by 132.19% to $3.4 million in 2026.
• The last three Cost of Revenue figures came in at $3.4 million (Q1 2026), -$10.7 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.